Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027627 (metastases)
 103,950 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We conducted a clinical trial evaluating the effects of hyperthermia in patients with carcinoma of the prostate, treating 20 patients with newly diagnosed carcinoma of the prostate with local microwave hyperthermia (915 MHz). Histological examination revealed hypoeremic effects and diffuse oedema with interstitial lymphoplasmatic cellular infiltration. However, necrotic tumour cells were not found in any of specimens. A second series consisted of 10 patients with metastasizing carcinoma of the prostate (n = 4 untreated; n = 6 hormone-resistant). For 8 weeks, epirubicin was administered once weekly, followed each time by local microwave hyperthermia 1 h later. The efficacy was evaluated according to the EORTC criteria. In 4 patients with untreated carcinoma no change was found in the size of the prostate or metastases. In 3 of the 6 patients with hormone-resistant carcinoma progressive disease was found, while the other 3 had stable disease. Only in 2 of the 10 patients did the grading of tumour regression reveal any improvement. Cytophotometric studies showed no change of DNA ploidy. Currently we consider hyperthermia unsuitable as monotherapy for carcinoma of the prostate, and the combination of epirubicin and hyperthermia is no more favourable than monotherapy with epirubicin alone. Further studies are necessary to evaluate other cytotoxic regimens and various patterns of application for hyperthermia.
 ...
PMID:[Local hyperthermia in prostate cancer]. 187 41

During a 6-year period, 53 patients with advanced tumors of the genitourinary tract were treated in Phase I protocols with deep regional hyperthermia in combination with irradiation (83%) or in combination with chemotherapy (11%). Primary tumors included those of bladder in 22 patients (41%), prostate in 20 patients (37%), kidney in 9 patients (17%), and ureter testicle or adrenal in 3 patients (5%). The majority (77%) had prior definitive therapy and had experienced treatment failure, and 11% had clinically important distant metastases. Treatment consisted of deep regional hyperthermia (mean of 4 sessions). In addition, 44 patients (83%) received irradiation (mean dose 39.2 Gy). The 1- and 3-year actuarial survival was 60% and 56%, respectively. Patients with carcinoma of the prostate had a 1- and 3-year survival of 82%. Complete response was observed in 7 patients (13%), partial response in 8 (15%), and nominal response in 13 (25%). Complete and partial response correlated well with histology of the tumor (adenocarcinoma), radiation dose (greater than 50 Gy), primary site (prostate, kidney), and treatment (hyperthermia-radiotherapy combination), (p = 0.02). There was no such correlation between response and thermal dose (p = 0.13). The treatment tolerance was good in 79% of patients. Treatment toxicity was limited to acute side effects, including pain during hyperthermia (47%), tachycardia greater than 140/min (7%), and blister formation in the treated area (4%). Phase II studies in previously untreated patients with locally advanced tumors of bladder, prostate, and kidney are needed for evaluation of the role of deep regional hyperthermia in the management of these cancers.
 ...
PMID:Regional hyperthermia in patients with recurrent genitourinary cancer. 195 35

In almost 80% of all skeletal metastases of carcinoma of the prostate, osteoneogenesis by "normal" osteoblasts can be detected in the surrounding tissue. The object of the present study was to perform a quantitative histomorphometric analysis of this local osteoblast stimulation. In tissue with metastases, the relative proportion of osteoid and mineralized bone tissue per unit of volume (Vv = 46%) was three times higher than the norm (Vv = 15%). Although the lamellar spongiosa (Pm = 19%) was only slightly higher than the physiological values (Pm = 15%), a considerable increase in fibrous bone tissue (PFK = 39%) was found (normal value: 1-2%). The volumetric density of the osteoid (POST = 7%) had also increased (normal value: 7%). While the mean width of the trabecula of the lamellar spongiosa was within normal range (dTRAB/LK = 136 microns), appositional accumulation of a 62 microns thick fibrous bone layer resulted in a distinct tumefaction of the trabeculae. The width of the osteoid border (dapp.OST) was 22 microns (normal value: 13 microns). The majority of the activated osteoblasts were 30-150 microns from the neighboring tumor cells.
 ...
PMID:[Stimulation of osteoblasts in skeletal metastases--a quantitative study]. 214 31

Small cell carcinomas of the urinary tract are rare, but lethal. We report 3 cases of primary small cell carcinoma of the kidney, urinary bladder and prostate with light microscopic, immunohistochemical and electron microscopic findings. One patient with small cell carcinoma of the prostate died of disseminated disease 2 years after diagnosis and another patient with small cell carcinoma of the urinary bladder was free of tumour after 6 months. A partial remission was induced in the third patient with distant metastases of small cell carcinoma of the kidney by using chemotherapy protocols similar to the drug regimens for small cell carcinomas of the lung; the patient survived for 5 months. Immunohistochemical studies revealed the absence of argyrophilic immunostaining of tumour cells in all 3 cases, positive staining for keratin in 2 and staining for neuron-specific enolase in all 3. In the third patient, reactivity for prostate-specific antigen was negative. Dense-core, membrane-bound granules were identified in the cytoplasm of 2 patients. The paraneoplastic syndrome was not found, indicating that in considering the occurrence of ectopic hormones, specific cytoplasmic granules of origin need not be implicated. Recognition of this distinct entity requires full consideration of morphological, immunohistological, ultrastructural and biological features. In order to define the origin of this tumour more clearly and to evaluate the effectiveness of chemotherapy, larger series of patients are needed.
 ...
PMID:Small cell carcinoma of the urinary tract. 217 13

Metastatic involvement of the larynx by carcinoma of the prostate is a rare event: only 5 cases are recorded in the English literature. We report a case of prostatic carcinoma with symptomatic metastasis to the right vocal cord. Five months after the diagnosis of metastatic disease in the vocal cord the patient died of widespread metastases. We report the sixth case of this event and review the reported cases in the literature.
 ...
PMID:Carcinoma of prostate metastasizing to vocal cord. 219 45

The mean age of 100 patients who underwent orchiectomy for carcinoma of the prostate was 76.4 years. 50% of the patients had distant metastases. Almost all had a locally advanced tumour. 49 patients were operated by orchiectomy only. On 51 occasions, a transurethral resection of the prostate was carried out under the same anesthesia. In 22 patients, operation of the prostate was done without previous planning, "because the patient was already on the operating table". Mean stay in hospital varied from 11.2 to 15.6 days, depending on the extent of the operative treatment. Social factors were the most important reason for prolonged hospitalization. Patients who are offered castration in the treatment of prostatic cancer have a great latent need for medical service and social care.
 ...
PMID:[Medical or surgical castration in prostatic cancer? Experience of 100 orchiectomies]. 230 93

The red cell membrane stearic acid to oleic acid ratio was analysed in 34 men with histologically proven carcinoma of the prostate and distant metastases. This ratio was expressed as the saturation index (SI). A mean SI of 0.97 was found in control patients without evidence of any malignancy whereas all patients with advanced prostatic cancer showed a reduced stearic to oleic acid ratio (mean SI 0.466). Untreated patients had a significantly lower SI (mean 0.36) than those who had responded to hormonal therapy (mean 0.547; P less than 0.0001). A drop in SI correlated well with more advanced disease as judged by radiological findings and serum PSA. It is suggested that red cell membrane SI correlates well with radiological and biochemical markers of advanced prostatic carcinoma and may be used as a marker to assess progress and response to treatment.
 ...
PMID:Erythrocyte stearic to oleic acid ratio in prostatic carcinoma. 233 46

There is little information on histological changes in prostate cancer during the course of the disease. We have studied 74 patients with carcinoma of the prostate who required 2 transurethral resections of the prostate (mean interval between resections 2.4 years). They constituted 18.4% of all patients with carcinoma of the prostate presenting to our clinic between January 1978 and April 1988. All tumours were staged by conventional methods and graded using the Gleason system. The Gleason sum score in those patients with tumour in both specimens increased in 49, remained constant in 12 and decreased in 7. Within this group were 34 patients who were treated expectantly. The mean Gleason sum scores in this group increased, with a concomitant increase in local tumour stage and development of metastases. Although this was not a randomised trial, there was no significant difference in survival between patients having "deferred" management and those treated immediately, either from time of diagnosis or from time of second resection. There was, however, a significant difference in the time to second resection, with the "deferred" group requiring repeat resection on average 1 year earlier. This study confirmed the concept of tumour de-differentiation with time and showed that this phenomenon occurs in both treated and untreated tumours. Although overall survival was not influenced by the type of initial therapy or its timing, local progression, as assessed by the need for further TURP, occurred earlier in those not receiving immediate therapy.
 ...
PMID:De-differentiation with time in prostate cancer and the influence of treatment on the course of the disease. 233 47

Prostatic carcinoma metastasising to the penis is a rare occurrence with only 56 cases reported in the literature. The incidence of transitional cell carcinoma arising primarily in the prostate ranges from 1. 5 to 4%. These tumors have uniformly poor prognosis regardless the type of therapy. Most of the patients die within two to six moths and very few survive beyond twelve months. A case of transitional cell carcinoma of the prostate with penile metastases and priapism is presented.
 ...
PMID:Transitional cell carcinoma of the prostate metastatic to penis as cause of priapism. 236 66

In some retrospective studies perioperative transfusions during oncologic surgery have been shown to decrease the time interval between surgery and local and/or distant recurrence of cancer. This study examines the disease-related effect, if any, of perioperative blood transfusions among 108 patients with localized carcinoma of the prostate treated by radioactive iodine-125 seed implantation of the prostate and lymphadenectomy. When all subjects were analyzed, there was no statistical difference of local and distant failure between the transfused and nontransfused groups. Patients with well-differentiated tumors had statistically fewer local recurrences (0% vs 22%, p = 0.036) if they were transfused perioperatively. However, the difference in distant metastases (0% vs 11%) was not statistically significant (p = 0.21). In contrast, patients with moderately and poorly differentiated disease receiving transfusions had more local recurrences and metastases, though this was not statistically significant. Our data suggest that there is no obvious evidence that perioperative blood transfusions have an adverse effect on local recurrence or distant metastases for iodine-125 seed implantation of carcinoma of the prostate.
 ...
PMID:Disease-related effects of perioperative blood transfusions associated with 125I seed implantation for prostate carcinoma. 238 75


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>